Moringa
Supplement
botanical
general nutritionenergy
Not medical advice. Check with your doctor or pharmacist before you start, stop or change the timing of anything you take.
How to use
What it’s for
2025 meta-analysis: no consistent cardiometabolic benefit
Studied for
Subgroup signal appeared past 12 weeks, at under 10 g/day
Pros & cons
Pros
- 9 RCTS, 341 vs 308 adults, cochrane rob 2 + grade
- Diastolic bp fell modestly (smd −0.41)
- Subgroups under 10 g/day and past 12 weeks did better
Cons
- No significant effect on most outcomes pooled
- Certainty of evidence: very low for every outcome
- Heterogeneity often above 80%; dbp effect not robust
Sources
- Crișan et al., Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of RCTs with GRADE Assessment (Nutrients 2025, PMID 41305552) — scope and headline · read 2026-08-27
what it says
“Nine RCTs (12 study arms) involving 341 participants in the intervention and 308 in the control groups met inclusion criteria. Moringa supplementation showed no significant effects on most considered outcomes.”
- Crișan et al. 2025 (PMID 41305552) — methods · read 2026-08-27
what it says
“risk of bias was assessed using the Cochrane RoB 2 tool, while the certainty of evidence was evaluated using GRADE assessment”
- Crișan et al. 2025 (PMID 41305552) — diastolic blood pressure · read 2026-08-27
what it says
“A modest reduction in diastolic blood pressure (SMD: -0.41; 95% CI: -0.75 to -0.07) was observed; however, this effect was not robust in sensitivity analyses.”
- Crișan et al. 2025 (PMID 41305552) — subgroup analyses · read 2026-08-27
what it says
“Subgroup analyses suggested potential benefits at doses <10 g/day, in participants <50 years old, and in interventions lasting ≥12 weeks.”
- Crișan et al. 2025 (PMID 41305552) — certainty of evidence and conclusion · read 2026-08-27
what it says
“risk of bias, substantial heterogeneity (I² frequently >80%), indirectness, and methodological limitations reduced the overall certainty of evidence to very low for all the evaluated outcomes … Current evidence does not support consistent cardiometabolic benefits”
- Soto et al., Biological properties of Moringa oleifera: A systematic review of the last decade (F1000Research 2024, PMID 39895949) · read 2026-08-27
what it says
“the biological activity of Moringa oleifera in human health was explored through a review of 129 original articles published between 2010 and 2021 … Moringa oleifera extracts showed antioxidant, hypoglycemic, antihypertensive and cytoprotective properties”
- HSA Singapore — Guidelines on Prohibited and Restricted Ingredients in Health Supplements and Traditional Medicines, GL-CHPB-1-012 Rev. No. 001 (October 2025), Annex A (118 rows) and Annex B (4 rows) — Moringa oleifera NOT LISTED in either (Annex A neighbours: 64. Magnolia officinalis, 71. Mucuna) · read 2026-08-27
what it says
“The objective of this guideline is to highlight the substances of concern when used in HS and TM and is not meant to be an exhaustive list.”
- HSA Singapore — Health Supplements Guidelines GL-CHPB-3-001 Rev. No. 020 (January 2026), clause 4.8 with Tables 4–5 (vitamins and minerals only — no botanical or bee-product rows) · read 2026-08-27
what it says
“4.8 HS for use by the general adult population should not contain vitamins and minerals exceeding the stipulated limits stated in Tables 4 and 5.”
- iHerb Singapore — Moringa category page, default listing order · read 2026-08-27
what it says
“1 - 48 of 57 results … MRM Nutrition, Moringa Leaf … MRM Nutrition, Organic Moringa Powder … Nature's Truth, Moringa Oleifera … Swanson Vitamins, Full Spectrum® Moringa Oleifera, 400 mg … Micro Ingredients, Organic Moringa Powder … Organic India, Moringa”
Updated 2026-08-29. Every line above traces to a numbered source. Kozen-X is not a medical device and does not give medical advice. It lists what published sources have written down — nothing more. A pair not listed is unrecorded, not cleared. Before you start, stop or re-time anything, talk to your doctor or pharmacist.